Terms: = Leukemia AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
27 results:
1. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract] [Full Text] [Related]
2. B-Lymphoblastic leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract] [Full Text] [Related]
3. Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab.
Felberg A; Taszner M; Urban A; Majeranowski A; Jaskuła K; Jurkiewicz A; Stasiłojć G; Blom AM; Zaucha JM; Okrój M
Front Immunol; 2020; 11():584509. PubMed ID: 33329558
[TBL] [Abstract] [Full Text] [Related]
4. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
5. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.
Debant M; Burgos M; Hemon P; Buscaglia P; Fali T; Melayah S; Le Goux N; Vandier C; Potier-Cartereau M; Pers JO; Tempescul A; Berthou C; Bagacean C; Mignen O; Renaudineau Y
J Immunother Cancer; 2019 Apr; 7(1):111. PubMed ID: 31014395
[TBL] [Abstract] [Full Text] [Related]
6. [Primary plasma cell leukemia. Report of five cases].
Mendoza MG; Valladares X; Roa M; Reyes M; Osorio R; Undurraga MS; Legües ME; Cabrera ME; Peña C
Rev Med Chil; 2019; 147(1):18-23. PubMed ID: 30848760
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
[TBL] [Abstract] [Full Text] [Related]
8. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract] [Full Text] [Related]
9. Chronic lymphocytic leukaemia.
Hallek M; Shanafelt TD; Eichhorst B
Lancet; 2018 Apr; 391(10129):1524-1537. PubMed ID: 29477250
[TBL] [Abstract] [Full Text] [Related]
10. Rituximab in the management of acute lymphoblastic leukemia.
Levato L; Molica S
Expert Opin Biol Ther; 2018 Feb; 18(2):221-226. PubMed ID: 29310477
[TBL] [Abstract] [Full Text] [Related]
11. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.
Cruz-Rodriguez N; Combita AL; Enciso LJ; Raney LF; Pinzon PL; Lozano OC; Campos AM; Peñaloza N; Solano J; Herrera MV; Zabaleta J; Quijano S
J Exp Clin Cancer Res; 2017 Feb; 36(1):37. PubMed ID: 28245840
[TBL] [Abstract] [Full Text] [Related]
13. Improving therapeutic activity of anti-cd20 antibody therapy through immunomodulation in lymphoid malignancies.
Lipowska-Bhalla G; Fagnano E; Illidge TM; Cheadle EJ
Leuk Lymphoma; 2016; 57(6):1269-80. PubMed ID: 27050042
[TBL] [Abstract] [Full Text] [Related]
14. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract] [Full Text] [Related]
15. The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-cd20 Antibodies.
Ahmadzadeh V; Tofigh R; Farajnia S; Pouladi N
Int Rev Immunol; 2016; 35(2):136-55. PubMed ID: 26325124
[TBL] [Abstract] [Full Text] [Related]
16. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract] [Full Text] [Related]
17. Immunotherapy with the trifunctional anti-cd20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent cd20-positive B cell malignancies.
Schuster FR; Stanglmaier M; Woessmann W; Winkler B; Siepermann M; Meisel R; Schlegel PG; Hess J; Lindhofer H; Borkhardt A; Buhmann R
Br J Haematol; 2015 Apr; 169(1):90-102. PubMed ID: 25495919
[TBL] [Abstract] [Full Text] [Related]
18. Definition of remission, minimal residual disease, and relapse in hairy cell leukemia bone marrow biopsy histology and immunohistology specimens.
Noel P
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():62-4. PubMed ID: 21463123
[TBL] [Abstract] [Full Text] [Related]
19. Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.
Nambu T; Hamada A; Nakashima R; Yuki M; Kawaguchi T; Mitsuya H; Saito H
Biol Pharm Bull; 2011; 34(1):114-9. PubMed ID: 21212528
[TBL] [Abstract] [Full Text] [Related]
20. Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia.
Shanafelt TD; Rabe KG; Kay NE; Zent CS; Call TG; Slager SL; Bowen DA; Schwager SM; Nowakowski GS
Leuk Lymphoma; 2010 Jul; 51(7):1233-40. PubMed ID: 20496995
[TBL] [Abstract] [Full Text] [Related]
[Next]
